Terms: = Uterine cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Treatment
9 results:
1. A Novel Prognostic Risk Model for Cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
2. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract] [Full Text] [Related]
3. Surgical wait time: A new health indicator in women with endometrial cancer.
Strohl AE; Feinglass JM; Shahabi S; Simon MA
Gynecol Oncol; 2016 Jun; 141(3):511-515. PubMed ID: 27103178
[TBL] [Abstract] [Full Text] [Related]
4. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell uterine cancer: Is Observation a Valid Strategy?
Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
[TBL] [Abstract] [Full Text] [Related]
5. Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.
Yoshioka T; Yogosawa S; Yamada T; Kitawaki J; Sakai T
Gynecol Oncol; 2013 May; 129(2):425-32. PubMed ID: 23403163
[TBL] [Abstract] [Full Text] [Related]
6. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Zhao S; Choi M; Overton JD; Bellone S; Roque DM; Cocco E; Guzzo F; English DP; Varughese J; Gasparrini S; Bortolomai I; Buza N; Hui P; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Carrara L; Pecorelli S; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Stiegler AL; Mane S; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2916-21. PubMed ID: 23359684
[TBL] [Abstract] [Full Text] [Related]
7. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
[TBL] [Abstract] [Full Text] [Related]
8. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract] [Full Text] [Related]
9. Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mangiacotti MG; Margariti PA; Ferrandina G; Scambia G
Tumori; 2005; 91(3):215-20. PubMed ID: 16206643
[TBL] [Abstract] [Full Text] [Related]